Felder R A, Felder C C, Eisner G M, Jose P A
University of Virginia Medical Center, Charlottesville 22908.
Am J Physiol. 1989 Sep;257(3 Pt 2):F315-27. doi: 10.1152/ajprenal.1989.257.3.F315.
Dopamine, like other neurotransmitters, exerts its biological effects by occupation of specific receptor subtypes. The dopamine receptors in the central nervous system and certain endocrine organs are classified into the D1/D2 subtypes. Outside the central nervous system, the dopamine receptors are classified into the DA1/DA2 subtypes. The D1/D2 and DA1/DA2 receptor have marked similarities and some differences, the most notable of which is the lower affinity of the DA dopamine compared with the D dopamine receptor. DA1 receptor activation increases renal blood flow (RBF); stimulation of DA1 and DA2 receptors may also increase glomerular filtration rate (GFR). DA1 agonists inhibit fluid and electrolyte transport indirectly via hemodynamic mechanisms and directly by occupation of DA1 receptors in specific nephron segments. In the proximal tubule, DA1 agonists simulate adenylate cyclase and inhibit Na+-H+ antiport activity. They also increase phospholipase C and inhibit Na+-K+-ATPase activity (presumably as a consequence of protein kinase C activation). The latter effects may be facilitated by DA2 agonists. In cortical collecting ducts, dopamine antagonizes the effects of mineralocorticoids and the hydrosomotic effect of antidiuretic hormone. It has also been suggested that DA1 may also decrease sodium transport by influencing other hormones, such as atrial natriuretic peptide. Studies of dopamine in the young are complicated because of the propensity for dopamine to stimulate alpha-adrenoceptors. Dopamine alone may actually decrease RBF in the perinatal period. In some animals, the renal vasodilatory and natriuretic effects of dopamine increase with age. Renal tubular DA1-stimulated adenylate cyclase activity increases, whereas renal tubular DA1 receptors decrease with age. Renal DA2 receptor density is greater in the fetus; after birth renal DA2 receptors do not change. Endogenous dopamine may regulate sodium excretion in the young differently than in the adult. In the adult, sodium surfeit is associated with an increase in urinary dopamine; the opposite occurs in the young. A decrease in dopamine production or blockade of dopamine receptors results in an antinatriuresis in the adult; dopamine blockade in the young results in a natriuresis. It remains to be determined whether these age-related differences in dopamine effects are due to changes in receptor DA subtype density, second messengers, and/or interaction with other receptors.
多巴胺与其他神经递质一样,通过占据特定受体亚型发挥其生物学效应。中枢神经系统和某些内分泌器官中的多巴胺受体分为D1/D2亚型。在中枢神经系统之外,多巴胺受体分为DA1/DA2亚型。D1/D2和DA1/DA2受体有显著的相似性和一些差异,其中最显著的是DA多巴胺受体与D多巴胺受体相比亲和力较低。DA1受体激活可增加肾血流量(RBF);刺激DA1和DA2受体也可能增加肾小球滤过率(GFR)。DA1激动剂通过血流动力学机制间接抑制液体和电解质转运,并通过占据特定肾单位节段中的DA1受体直接发挥作用。在近端小管中,DA1激动剂模拟腺苷酸环化酶并抑制Na+-H+反向转运活性。它们还增加磷脂酶C并抑制Na+-K+-ATP酶活性(可能是蛋白激酶C激活的结果)。DA2激动剂可能会促进后一种作用。在皮质集合管中,多巴胺拮抗盐皮质激素的作用和抗利尿激素的水渗透性作用。也有人提出,DA1也可能通过影响其他激素(如心房利钠肽)来减少钠转运。由于多巴胺有刺激α-肾上腺素能受体的倾向,因此对年轻人多巴胺的研究较为复杂。单独使用多巴胺实际上可能会在围产期减少肾血流量。在一些动物中,多巴胺的肾血管舒张和利钠作用会随着年龄的增长而增加。肾小管DA1刺激的腺苷酸环化酶活性增加,而肾小管DA1受体则随年龄增长而减少。胎儿期肾DA2受体密度较高;出生后肾DA2受体不变。内源性多巴胺对年轻人钠排泄的调节可能与成年人不同。在成年人中,钠摄入过多与尿多巴胺增加有关;而在年轻人中则相反。多巴胺产生减少或多巴胺受体阻断在成年人中会导致抗利尿钠作用;在年轻人中多巴胺阻断会导致利尿钠作用。这些多巴胺效应与年龄相关的差异是否归因于受体DA亚型密度、第二信使和/或与其他受体的相互作用,仍有待确定。